Cargando…
Hypertension and diabetes treatment affordability and government expenditures following changes in patient cost sharing in the “Farmácia popular” program in Brazil: an interrupted time series study
BACKGROUND: Increasing medicines availability and affordability is a key goal of Brazilian health policies. “Farmácia Popular” (FP) Program is one of the government’s key strategies to achieve this goal. Under FP, antihypertension (HTN) and antiglycemic (DM) medicines have been provided at subsidize...
Autores principales: | Emmerick, Isabel Cristina Martins, Campos, Mônica Rodrigues, da Silva, Rondineli Mendes, Chaves, Luisa Arueira, Bertoldi, Andréa Dâmaso, Ross-Degnan, Dennis, Luiza, Vera Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951004/ https://www.ncbi.nlm.nih.gov/pubmed/31914972 http://dx.doi.org/10.1186/s12889-019-8095-0 |
Ejemplares similares
-
Brazilian generics market change after Farmácia Popular program
por: Bertoldi, Andréa Dâmaso, et al.
Publicado: (2019) -
Retrospective interrupted time series examining hypertension and diabetes medicines usage following changes in patient cost sharing in the ‘Farmácia Popular’ programme in Brazil
por: Emmerick, Isabel Cristina Martins, et al.
Publicado: (2017) -
Applying a health system perspective to the evolving Farmácia Popular medicines access programme in Brazil
por: Luiza, Vera L, et al.
Publicado: (2018) -
Farmácia Popular Program: changes in geographic accessibility of medicines during ten years of a medicine subsidy policy in Brazil
por: Emmerick, Isabel Cristina Martins, et al.
Publicado: (2015) -
Costs of Public Pharmaceutical Services in Rio de Janeiro Compared to Farmácia Popular Program
por: da Silva, Rondineli Mendes, et al.
Publicado: (2016)